Выпуск
EpiBone CEO Nina Tandon on Growing Living Bone and Cartilage from Stem Cells
Inside Startup Investing with Chris Lustrino · 19 ноября 2026 г. · 27 мин
Nina Tandon trained as an electrical engineer and arrived at MIT planning to build brain-computer interfaces. Today she is the co-founder and CEO of EpiBone, a New York company that grows living bone and cartilage from stem cells, and six patients are already living with jawbone her team grew in a lab. Nina joins Chris Lustrino to explain how it works. For bone, EpiBone starts with a CT scan and a small sample of the patient's own fat, extracts the stem cells, puts them on a scaffold machined to the shape of the missing bone, and grows the graft for three to four weeks in a bioreactor that feeds and exercises the cells the way a body would. In the company's first human trial, a six-patient Phase 1/2 study run with the Cleveland Clinic and the San Francisco VA, surgeons used those grafts to rebuild part of the jaw. She also tells the story of one of those operations: a 14-hour surgery during COVID, a scrub nurse asking whether to prep the patient's hip for a bone harvest, and the answer. No. The bone was already in the room, in a jar. In this episode: ● Why EpiBone thinks a metal-and-plastic joint replacement is the wrong fix for a few millimeters of damaged cartilage ● What Phase 1, 2 and 3 trials each have to prove ● The trials ahead: a U.S. Air Force-funded extension of the jaw study, a knee trial the FDA cleared in 2023, and an injectable cartilage ● Why bone, cartilage and each body part need separate regulatory sign-off, and the reforms Nina is lobbying for ● How growing nose cartilage worked on the first try, and why testing in humans is still the bottleneck ● Custom versus off the shelf: when a made-to-order graft is worth a four-week wait ● Why a venture-backed biotech opened its round to everyday investors ● What success looks like two to three years out Guest: Nina Tandon, Co-Founder & CEO, EpiBone Host: Chris Lustrino, Founder & CEO, Kingscrowd EpiBone is raising now. To see Kingscrowd's full analyst breakdown and discover how you can invest, visit kingscrowd.com. Inside Startup Investing is the only podcast where you can invest in every guest. Subscribe so you never miss a founder interview. Disclosure: This episode is for informational purposes only and is not investment advice or a recommendation to buy any security. Investing in early-stage companies is risky and illiquid, and you may lose your entire investment. EpiBone's products are investigational and have not been approved by the FDA.